Experimental diabetes and chronic isoproterenol pretreatment in rats significantly depressed ventricular beta-adrenoceptor density and altered inotropic reactivity compared to controls.
Diabetic and isoproterenol-induced cardiomyopathies in rats share similar pathophysiological alterations in beta-adrenoceptor density and calcium utilization.
The present study was undertaken to compare the cardiomyopathies induced by experimental diabetes mellitus and chronic isoproterenol (ISO) pretreatment on inotropic reactivity of right ventricular strips from rats. One month after initiation of treatment, cardiac muscle was isolated and challenged with either the beta-adrenoceptor agonist ISO or the calcium channel activator Bay K 8644. Sensitivity and responsiveness to these agonists were determined. Crude membrane preparations were obtained from residual ventricular muscle and beta-adrenoceptor density determined using iodocyanopindolol. Isolated right ventricular strips from diabetic and ISO-treated rats demonstrated hyperresponsiveness to the inotropic effects of Bay K 8644 but subsensitivity to ISO. Ventricular beta-adrenoceptor density was found to be significantly depressed in membrane preparations from both diabetic and ISO-treated groups relative to controls. These data indicate that both forms of cardiomyopathy may affect inotropic reactivity through similar alterations to beta-adrenoceptors and calcium utilization.
Gunasekaran et al. (2008) studied Diabetic and isoproterenol-induced cardiomyopathies. Experimental diabetes mellitus and chronic isoproterenol (ISO) pretreatment vs. Controls was evaluated on Inotropic reactivity and beta-adrenoceptor density. Experimental diabetes and chronic isoproterenol pretreatment in rats significantly depressed ventricular beta-adrenoceptor density and altered inotropic reactivity compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: